Overview
Cellular and Molecular Life Sciences (CMLS) is a multidisciplinary Open Access journal covering the latest aspects of biological and biomedical research.
- Publishes articles covering molecular and cellular aspects of biomedicine, biochemistry and molecular biology, cell biology, neuroscience, pharmacology, cancer biology, and immunology.
- Dedicated sections include: Cancer Biology, Signaling Pathways and Cellular Metabolism, Infection and Immunity.
- Rapid editorial decision.
- International Editorial Board and readership, with over three million articles downloaded each year.
- Regular Topical Collections open for submission – see “Collections and calls for papers” on the sidebar.
- Editors-in-Chief
-
- Roberto Bruzzone,
- Jean-Leon Thomas
- Impact factor
- 8.0 (2022)
- 5 year impact factor
- 8.7 (2022)
- Submission to first decision (median)
- 11 days
- Downloads
- 3,369,643 (2023)
Latest articles
Journal updates
-
Cellular and Molecular Life Sciences is now fully open access!
We are excited to announce that Cellular and Molecular Life Sciences has now become a fully open access (OA) journal as of January 2024. This means that we will only be publishing articles as Open Access meaning content will be and freely available to readers worldwide, enabling the widest possible dissemination and reuse.
Journal information
- Electronic ISSN
- 1420-9071
- Print ISSN
- 1420-682X
- Abstracted and indexed in
-
- AGRICOLA
- BFI List
- BIOSIS
- Baidu
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Chimica
- Current Contents/Life Sciences
- Dimensions
- EBSCO
- EMBASE
- EMBiology
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- PubMedCentral
- Reaction Citation Index
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Zoological Record
- Copyright information